BNR
Burning Rock Biotech Limited
There isn't enough reported data to score BNR yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
BNR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
BNR's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
BNR PE Valuation
BNR has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
BNR Forward outlook
There aren't enough analyst estimates for BNR to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
BNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$9.65 | +$10.58 |
| Q1 2026 | -$8.45 | +$26.23 |
| Q4 2025 | -$7.77 | +$42.82 |
| Q3 2025 | -$17.38 | +$45.17 |
| Q2 2025 | -$20.23 | +$62.79 |
| Q1 2025 | -$34.68 | +$51.76 |
| Q4 2024 | -$50.59 | +$45.22 |
| Q3 2024 | -$62.55 | +$41.18 |
BNR is still losing money, but far less than before: $9.65 per share over the past year, against $216.37 at its worst in early 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over BNR on earnings quality, reporting a profit while its opponent remains loss making.
BNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $20.2M | -9.2% |
| Q1 2026 | $16.2M | -19% |
| Q4 2025 | $19M | +0.2% |
| Q3 2025 | $19.8M | +2.3% |
| Q2 2025 | $22.3M | +9.6% |
| Q1 2025 | $20M | +5.9% |
| Q4 2024 | $18.9M | +4.1% |
| Q3 2024 | $19.3M | +0.8% |
BNR's revenue is shrinking: $20M last quarter, down 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -5.6 points |
| Q1 2026 | -17% | -6.1 points |
| Q4 2025 | -9.5% | +56 points |
| Q3 2025 | -12% | +18 points |
| Q2 2025 | -7.7% | +74 points |
| Q1 2025 | -11% | +89 points |
| Q4 2024 | -65% | +72 points |
| Q3 2024 | -30% | +110 points |
BNR's operating margin was −13% last quarter, down 5.6 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over BNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over BNR on profitability, with a higher operating margin.
BNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.4M | +$3.3M |
| Q1 2026 | -$4.4M | -$867K |
| Q4 2025 | $2.7M | +30% |
| Q3 2025 | $2.5M | +$7M |
| Q2 2025 | -$6.7M | -$527.2K |
| Q1 2025 | -$3.5M | +$2.5M |
| Q4 2024 | $2M | +$5.7M |
| Q3 2024 | -$4.5M | +$2.6M |
BNR has burned cash in almost every quarter: −$3M over the past year, against −$13M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over BNR on cash generation, producing positive trailing cash flow while its opponent burns cash.
BNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +34.1K shares |
| 1 year | +0.9% | +9.2K shares |
| 3 years | +6% | +61.3K shares |
| 5 years | +4.3% | +45.2K shares |
| Available history | +369% | +854K shares |
BNR has 1M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $10,805 |
| Q3 2024 | — |
BNR hasn't bought back shares in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over BNR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
BNR Net Leverage
BNR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
BNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 34.9 | Neutral |
BNR's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
BNR PE vs Healthcare Sector
BNR has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
BNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 5.4% below |
| 20 week MA | $11.9 | 12% above |
| 50 week MA | $16.7 | 20% below |
| 100 week MA | $11.7 | 14% above |
| 200 week MA | $12.5 | 6.9% above |
BNR's trend is mixed: it's above three of its five weekly moving averages, and 6.9% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over BNR on trend strength, trading above more of its moving averages.
BNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $246.3 | $257.5 | +4.5% |
| 2021 | $257.5 | $105.0 | -59% |
| 2022 | $105.0 | $20.8 | -80% |
| 2023 | $20.8 | $9.30 | -55% |
| 2024 | $9.30 | $7.14 | -23% |
| 2025 | $7.14 | $21.2 | +197% |
| 2026 YTD | $21.2 | $13.3 | -37% |
BNR's yearly returns have swung widely, from +197% in 2025 to −80% in 2022. It's down 37% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over BNR on returns for 2026, with the stronger performance.